A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Clinical trial NCT07548840 · RECRUITING
Trial details
- NCT number
- NCT07548840
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-08
- Primary completion
- 2026-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.